Clinical trial
A Pilot Phase II Study to Determine the Safety and Efficacy of the Combination of ONTAK With CHOP in Peripheral T-Cell Lymphoma.
NCT00211185 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Phase II Study to Determine the Safety and Efficacy of the Combination of ONTAK With CHOP in Peripheral T-Cell Lymphoma.
- Lead sponsor
- Eisai Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 14, 2004
- Completion date
- December 23, 2009
- Enrollment
- 49 (actual)
- Sites
- 49
Conditions
As the registry lists them; a condition with its own page is linked.